Market News for Biogen Inc (BIIB)
Biogen says it expects revenue to fall in 2026 as its multiple sclerosis therapies continue to struggle....
Barrons - 2/6/2026 8:35:00 AM
More News for BIIB
Stock Analysis for BIIB
Related Stocks:
Biogen forecast 2026 profit above Wall Street estimates on Friday, banking on demand for newer medicines and its Alzheimer's treatment Leqembi as older multiple sclerosis drugs battle pressure from cheaper versions....
Reuters - 2/6/2026 7:10:37 AM
More News for BIIB
Stock Analysis for BIIB
Related Stocks:
